Headline News about Gilead Sciences
Peering Into Gilead Sciences's Recent Short Interest
August 20, 2024
Via Benzinga
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal
August 15, 2024
Via Benzinga
Exposures
Product Safety
Expert Outlook: Gilead Sciences Through The Eyes Of 8 Analysts
August 15, 2024
Via Benzinga
Gilead Sciences's Options Frenzy: What You Need to Know
July 30, 2024
Via Benzinga
This Is What Whales Are Betting On Gilead Sciences
July 25, 2024
Via Benzinga
Gilead Sciences (GILD) Q2 2024 Earnings Call Transcript
August 08, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
10 Health Care Stocks Whale Activity In Today's Session
July 26, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|